Meyeon Park

MD MAS

Director, Polycystic Kidney Disease Center of Excellence
Nephrologist

About me

Dr. Meyeon Park is a nephrologist who cares for patients affected in various ways by high blood pressure and kidney disease. She has a special focus on polycystic kidney disease (PKD) and directs UCSF's PKD center of excellence.

Park's research explores how heart disease and kidney disease influence each other. She is particularly interested in learning how lifestyle changes can help individuals with PKD.

Park earned her medical degree from the Perelman School of Medicine at the University of Pennsylvania. She then completed a residency in internal medicine at the Yale School of Medicine, followed by a fellowship in nephrology at UCSF. She also has a master of advanced study degree in clinical research from UCSF.

Park is a member of the American Society of Nephrology.

  • Education

    UCSF, M.A.S., Clinical Research, 2012

    Perelman School of Medicine, 2006

  • Residencies

    Yale University School of Medicine, Internal Medicine, 2009

  • Fellowship

    UCSF, Nephrology, 2011

  • Board Certifications

    Nephrology, American Board of Internal Medicine

  • Academic Title

    Associate Professor

  • Languages

    French

    Spanish

Nephrology and Hypertension Faculty Practice

400 Parnassus Ave., B1 Plaza Level
San Francisco, CA 94143

Polycystic Kidney Disease (PKD) Center of Excellence

400 Parnassus Ave., B1 Plaza Level
San Francisco, CA 94143

Decorative Caduceus

APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)

The APOLLO study is being done in an attempt to improve outcomes after kidney transplantation and to improve the safety of living kidney donation based upon variation in the apolipoprotein L1 gene (APOL1). Genes cont...

Recruiting

Decorative Caduceus

A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPK...

Primary Objective: To determine the effect of venglustat on the rate of total kidney volume (TKV) growth and estimated glomerular filtration rate (eGFR) decline in patients at risk of rapidly progressive Aut...

Recruiting

Decorative Caduceus

Study of the Efficacy and Safety of Tesevatinib in Subjects With ADPKD

The goal of the study is to compare and evaluate safety and efficacy of tesevatinib 50mg versus placebo in patients with ADPKD.

Recruiting

Share